Advertisement
JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M311786200 on February 19, 2004

J. Biol. Chem., Vol. 279, Issue 17, 18091-18097, April 23, 2004
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
279/17/18091    most recent
M311786200v1
Right arrow Submit a Letter to Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Miao, F.
Right arrow Articles by Natarajan, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Miao, F.
Right arrow Articles by Natarajan, R.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

In Vivo Chromatin Remodeling Events Leading to Inflammatory Gene Transcription under Diabetic Conditions*

Feng Miao, Irene Gaw Gonzalo, Linda Lanting, and Rama Natarajan{ddagger}

From the Gonda Diabetes Center, Beckman Research Institute of City of Hope, Duarte, California 91010

The transcription factor NF-{kappa}B (NF-{kappa}B) plays a pivotal role in regulating inflammatory gene expression. Its effects are optimized by various coactivators including histone acetyltransferases (HATs) such as CBP/p300 and p/CAF. Evidence shows that high glucose (HG) conditions mimicking diabetes can activate the transcription of NF-{kappa}B-regulated inflammatory genes. However, the underlying in vivo transcription and nuclear chromatin remodeling events are unknown. We therefore carried out chromatin immunoprecipitation (ChIP) assays in monocytes to identify 1) chromatin factors bound to the promoters of tumor necrosis factor-{alpha} (TNF-{alpha}) and related NF-{kappa}B-regulated genes under HG or diabetic conditions, 2) specific lysine (Lys (K)) residues on histone H3 (HH3) and HH4 acetylated in this process. HG treatment of THP-1 monocytes increased the transcriptional activity of NF-{kappa}B p65, which was augmented by CBP/p300 and p/CAF. ChIP assays showed that HG increased the recruitment of NF-{kappa}B p65, CPB, and p/CAF to the TNF-{alpha} and COX-2 promoters. Interestingly, ChIP assays also demonstrated concomitant acetylation of HH3 at Lys9 and Lys14, and HH4 at Lys5, Lys8, and Lys12 at the TNF-{alpha} and COX-2 promoters. Overexpression of histone deacetylase (HDAC) isoforms inhibited p65-mediated TNF-{alpha} transcription. In contrast, a HDAC inhibitor stimulated gene transcription and histone acetylation. Finally, we demonstrated increased HH3 acetylation at TNF-{alpha} and COX-2 promoters in human blood monocytes from type 1 and type 2 diabetic subjects relative to nondiabetic. These results show for the first time that diabetic conditions can increase in vivo recruitment of NF-{kappa}B and HATs, as well as histone acetylation at the promoters of inflammatory genes, leading to chromatin remodeling and transcription.


Received for publication, October 27, 2003 , and in revised form, February 4, 2004.

* This work was supported by National Institutes of Health Grants RO1 DK065073 and PO1 HL55798, by Juvenile Diabetes Foundation International, and in part by General Clinical Research Center Grant MO1RR00043 (awarded to City of Hope) from the National Center for Research Resources. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

{ddagger} To whom correspondence should be addressed: Gonda Diabetes Center, Beckman Research Inst. of the City of Hope, 1500 East Duarte Rd., Duarte, CA 91010. Tel.: 626-359-8111 (ext. 62289); Fax: 626-301-8136; E-mail: rnatarajan{at}coh.org.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Eur Heart JHome page
D. Pons, F. R. de Vries, P. J. van den Elsen, B. T. Heijmans, P. H.A. Quax, and J. W. Jukema
Epigenetic histone acetylation modifiers in vascular remodelling: new targets for therapy in cardiovascular disease
Eur. Heart J., February 1, 2009; 30(3): 266 - 277.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
C. Nacci, M. Tarquinio, L. De Benedictis, A. Mauro, A. Zigrino, M. R. Carratu, M. J. Quon, and M. Montagnani
Endothelial Dysfunction in Mice with Streptozotocin-induced Type 1 Diabetes Is Opposed by Compensatory Overexpression of Cyclooxygenase-2 in the Vasculature
Endocrinology, February 1, 2009; 150(2): 849 - 861.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
S. C. Degner, A. J. Papoutsis, O. Selmin, and D. F. Romagnolo
Targeting of Aryl Hydrocarbon Receptor-Mediated Activation of Cyclooxygenase-2 Expression by the Indole-3-Carbinol Metabolite 3,3'-Diindolylmethane in Breast Cancer Cells
J. Nutr., January 1, 2009; 139(1): 26 - 32.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
F. Miao, D. D. Smith, L. Zhang, A. Min, W. Feng, and R. Natarajan
Lymphocytes From Patients With Type 1 Diabetes Display a Distinct Profile of Chromatin Histone H3 Lysine 9 Dimethylation: An Epigenetic Study in Diabetes
Diabetes, December 1, 2008; 57(12): 3189 - 3198.
[Abstract] [Full Text] [PDF]


Home page
JEMHome page
A. El-Osta, D. Brasacchio, D. Yao, A. Pocai, P. L. Jones, R. G. Roeder, M. E. Cooper, and M. Brownlee
Transient high glucose causes persistent epigenetic changes and altered gene expression during subsequent normoglycemia
J. Exp. Med., September 29, 2008; 205(10): 2409 - 2417.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
Y. Li, M. A. Reddy, F. Miao, N. Shanmugam, J.-K. Yee, D. Hawkins, B. Ren, and R. Natarajan
Role of the Histone H3 Lysine 4 Methyltransferase, SET7/9, in the Regulation of NF-{kappa}B-dependent Inflammatory Genes: RELEVANCE TO DIABETES AND INFLAMMATION
J. Biol. Chem., September 26, 2008; 283(39): 26771 - 26781.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
M. A. Reddy, L. M. Villeneuve, M. Wang, L. Lanting, and R. Natarajan
Role of the Lysine-Specific Demethylase 1 in the Proinflammatory Phenotype of Vascular Smooth Muscle Cells of Diabetic Mice
Circ. Res., September 12, 2008; 103(6): 615 - 623.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
D. L. Clarke, A. Sutcliffe, K. Deacon, D. Bradbury, L. Corbett, and A. J. Knox
PKC{beta}II Augments NF-{kappa}B-Dependent Transcription at the CCL11 Promoter via p300/CBP-Associated Factor Recruitment and Histone H4 Acetylation
J. Immunol., September 1, 2008; 181(5): 3503 - 3514.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
G. J. Brunn, S. Saadi, and J. L. Platt
Constitutive Repression of Interleukin-1{alpha} in Endothelial Cells
Circ. Res., April 11, 2008; 102(7): 823 - 830.
[Abstract] [Full Text] [PDF]


Home page
Rheumatology (Oxford)Home page
C. Nakamura, I. Matsushita, E. Kosaka, T. Kondo, and T. Kimura
Anti-arthritic effects of combined treatment with histone deacetylase inhibitor and low-intensity ultrasound in the presence of microbubbles in human rheumatoid synovial cells
Rheumatology, April 1, 2008; 47(4): 418 - 424.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
C. M. Johnson and R. I. Tapping
Microbial Products Stimulate Human Toll-like Receptor 2 Expression through Histone Modification Surrounding a Proximal NF-{kappa}B-binding Site
J. Biol. Chem., October 26, 2007; 282(43): 31197 - 31205.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. E. Gazzar, B. K. Yoza, J. Y.-Q. Hu, S. L. Cousart, and C. E. McCall
Epigenetic Silencing of Tumor Necrosis Factor {alpha} during Endotoxin Tolerance
J. Biol. Chem., September 14, 2007; 282(37): 26857 - 26864.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
B. Yamini, X. Yu, M. E. Dolan, M. H. Wu, D. W. Kufe, and R. R. Weichselbaum
Inhibition of Nuclear Factor-{kappa}B Activity by Temozolomide Involves O6-Methylguanine Induced Inhibition of p65 DNA Binding
Cancer Res., July 15, 2007; 67(14): 6889 - 6898.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
K. E. Sullivan, A. B. M. Reddy, K. Dietzmann, A. R. Suriano, V. P. Kocieda, M. Stewart, and M. Bhatia
Epigenetic Regulation of Tumor Necrosis Factor Alpha
Mol. Cell. Biol., July 15, 2007; 27(14): 5147 - 5160.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
F. Miao, X. Wu, L. Zhang, Y.-C. Yuan, A. D. Riggs, and R. Natarajan
Genome-wide Analysis of Histone Lysine Methylation Variations Caused by Diabetic Conditions in Human Monocytes
J. Biol. Chem., May 4, 2007; 282(18): 13854 - 13863.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
M. Kato, J. Zhang, M. Wang, L. Lanting, H. Yuan, J. J. Rossi, and R. Natarajan
MicroRNA-192 in diabetic kidney glomeruli and its function in TGF-beta-induced collagen expression via inhibition of E-box repressors
PNAS, February 27, 2007; 104(9): 3432 - 3437.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
S.-l. Li, M. A. Reddy, Q. Cai, L. Meng, H. Yuan, L. Lanting, and R. Natarajan
Enhanced Proatherogenic Responses in Macrophages and Vascular Smooth Muscle Cells Derived From Diabetic db/db Mice
Diabetes, September 1, 2006; 55(9): 2611 - 2619.
[Abstract] [Full Text] [PDF]


Home page
Toxicol SciHome page
J. Pestka and H.-R. Zhou
Toll-Like Receptor Priming Sensitizes Macrophages to Proinflammatory Cytokine Gene Induction by Deoxynivalenol and Other Toxicants
Toxicol. Sci., August 1, 2006; 92(2): 445 - 455.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
F. Miao, S. Li, V. Chavez, L. Lanting, and R. Natarajan
Coactivator-Associated Arginine Methyltransferase-1 Enhances Nuclear Factor-{kappa}B-Mediated Gene Transcription through Methylation of Histone H3 at Arginine 17
Mol. Endocrinol., July 1, 2006; 20(7): 1562 - 1573.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
P. Szulakowski, A. J. L. Crowther, L. A. Jimenez, K. Donaldson, R. Mayer, T. B. Leonard, W. MacNee, and E. M. Drost
The Effect of Smoking on the Transcriptional Regulation of Lung Inflammation in Patients with Chronic Obstructive Pulmonary Disease
Am. J. Respir. Crit. Care Med., July 1, 2006; 174(1): 41 - 50.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
H. Das, A. Kumar, Z. Lin, W. D. Patino, P. M. Hwang, M. W. Feinberg, P. K. Majumder, and M. K. Jain
Kruppel-like factor 2 (KLF2) regulates proinflammatory activation of monocytes
PNAS, April 25, 2006; 103(17): 6653 - 6658.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. E. Fish, C. C. Matouk, A. Rachlis, S. Lin, S. C. Tai, C. D'Abreo, and P. A. Marsden
The Expression of Endothelial Nitric-oxide Synthase Is Controlled by a Cell-specific Histone Code
J. Biol. Chem., July 1, 2005; 280(26): 24824 - 24838.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
F. Miao and R. Natarajan
Mapping Global Histone Methylation Patterns in the Coding Regions of Human Genes
Mol. Cell. Biol., June 1, 2005; 25(11): 4650 - 4661.
[Abstract] [Full Text] [PDF]


Home page
Physiol. GenomicsHome page
J. R. Wood, V. L. Nelson-Degrave, E. Jansen, J. M. McAllister, S. Mosselman, and J. F. Strauss III
Valproate-induced alterations in human theca cell gene expression: clues to the association between valproate use and metabolic side effects
Physiol Genomics, February 10, 2005; 20(3): 233 - 243.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
R. Natarajan and J. L. Nadler
Lipid Inflammatory Mediators in Diabetic Vascular Disease
Arterioscler. Thromb. Vasc. Biol., September 1, 2004; 24(9): 1542 - 1548.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2004 by the American Society for Biochemistry and Molecular Biology.
Advertisement
spacer
Advertisement
Advertisement